nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A1—Estropipate—osteoporosis	0.213	0.351	CbGbCtD
Procainamide—SLC22A3—Estradiol—osteoporosis	0.172	0.283	CbGbCtD
Procainamide—SLC22A2—Estradiol—osteoporosis	0.102	0.168	CbGbCtD
Procainamide—SLC22A1—Estradiol—osteoporosis	0.0886	0.146	CbGbCtD
Procainamide—CYP2D6—Cholecalciferol—osteoporosis	0.0317	0.0522	CbGbCtD
Procainamide—DNMT1—Fulvestrant—Estradiol—osteoporosis	0.00509	1	CbGdCrCtD
Procainamide—Dysgeusia—Calcitriol—osteoporosis	0.000985	0.00336	CcSEcCtD
Procainamide—Ill-defined disorder—Alendronate—osteoporosis	0.00098	0.00334	CcSEcCtD
Procainamide—Angioedema—Estropipate—osteoporosis	0.00098	0.00334	CcSEcCtD
Procainamide—Vomiting—Calcium Acetate—osteoporosis	0.000979	0.00334	CcSEcCtD
Procainamide—Asthenia—Ergocalciferol—osteoporosis	0.000976	0.00333	CcSEcCtD
Procainamide—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.000975	0.00332	CcSEcCtD
Procainamide—Arthritis—Estradiol—osteoporosis	0.000969	0.0033	CcSEcCtD
Procainamide—Angioedema—Alendronate—osteoporosis	0.000965	0.00329	CcSEcCtD
Procainamide—Agranulocytosis—Pamidronate—osteoporosis	0.000962	0.00328	CcSEcCtD
Procainamide—Lethargy—Estradiol—osteoporosis	0.000961	0.00327	CcSEcCtD
Procainamide—Ill-defined disorder—Ibandronate—osteoporosis	0.000954	0.00325	CcSEcCtD
Procainamide—Malaise—Alendronate—osteoporosis	0.000952	0.00324	CcSEcCtD
Procainamide—Angioedema—Ibandronate—osteoporosis	0.000939	0.0032	CcSEcCtD
Procainamide—Depression—Zoledronate—osteoporosis	0.000939	0.0032	CcSEcCtD
Procainamide—Malaise—Ibandronate—osteoporosis	0.000927	0.00316	CcSEcCtD
Procainamide—Renal failure—Zoledronate—osteoporosis	0.000925	0.00315	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000921	0.00314	CcSEcCtD
Procainamide—Nausea—Calcium Acetate—osteoporosis	0.000915	0.00312	CcSEcCtD
Procainamide—Myalgia—Estropipate—osteoporosis	0.000913	0.00311	CcSEcCtD
Procainamide—Arthralgia—Estropipate—osteoporosis	0.000913	0.00311	CcSEcCtD
Procainamide—Depression—Conjugated Estrogens—osteoporosis	0.000904	0.00308	CcSEcCtD
Procainamide—Cardiac disorder—Risedronate—osteoporosis	0.000903	0.00308	CcSEcCtD
Procainamide—Myalgia—Alendronate—osteoporosis	0.000899	0.00306	CcSEcCtD
Procainamide—Renal failure—Conjugated Estrogens—osteoporosis	0.000891	0.00304	CcSEcCtD
Procainamide—Discomfort—Alendronate—osteoporosis	0.000888	0.00303	CcSEcCtD
Procainamide—Myalgia—Raloxifene—osteoporosis	0.000884	0.00301	CcSEcCtD
Procainamide—Arthralgia—Raloxifene—osteoporosis	0.000884	0.00301	CcSEcCtD
Procainamide—Agranulocytosis—Zoledronate—osteoporosis	0.000878	0.00299	CcSEcCtD
Procainamide—Myalgia—Ibandronate—osteoporosis	0.000875	0.00298	CcSEcCtD
Procainamide—Arthralgia—Ibandronate—osteoporosis	0.000875	0.00298	CcSEcCtD
Procainamide—Convulsion—Calcitriol—osteoporosis	0.000872	0.00297	CcSEcCtD
Procainamide—Discomfort—Ibandronate—osteoporosis	0.000865	0.00295	CcSEcCtD
Procainamide—Bradycardia—Zoledronate—osteoporosis	0.00086	0.00293	CcSEcCtD
Procainamide—Abdominal pain upper—Estradiol—osteoporosis	0.00086	0.00293	CcSEcCtD
Procainamide—Flushing—Pamidronate—osteoporosis	0.000859	0.00292	CcSEcCtD
Procainamide—Cardiac disorder—Pamidronate—osteoporosis	0.000859	0.00292	CcSEcCtD
Procainamide—Myalgia—Calcitriol—osteoporosis	0.000857	0.00292	CcSEcCtD
Procainamide—Discomfort—Calcitriol—osteoporosis	0.000846	0.00288	CcSEcCtD
Procainamide—Shock—Raloxifene—osteoporosis	0.000834	0.00284	CcSEcCtD
Procainamide—Feeling abnormal—Etidronic acid—osteoporosis	0.000833	0.00284	CcSEcCtD
Procainamide—Chills—Pamidronate—osteoporosis	0.00083	0.00283	CcSEcCtD
Procainamide—Thrombocytopenia—Raloxifene—osteoporosis	0.00083	0.00283	CcSEcCtD
Procainamide—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000827	0.00282	CcSEcCtD
Procainamide—Shock—Ibandronate—osteoporosis	0.000825	0.00281	CcSEcCtD
Procainamide—Nausea—Ergocalciferol—osteoporosis	0.000808	0.00275	CcSEcCtD
Procainamide—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000806	0.00275	CcSEcCtD
Procainamide—Urticaria—Etidronic acid—osteoporosis	0.000803	0.00274	CcSEcCtD
Procainamide—Abdominal pain—Etidronic acid—osteoporosis	0.000799	0.00272	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000797	0.00272	CcSEcCtD
Procainamide—Angioedema—Ethinyl Estradiol—osteoporosis	0.000794	0.0027	CcSEcCtD
Procainamide—Dysgeusia—Pamidronate—osteoporosis	0.000789	0.00269	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000785	0.00267	CcSEcCtD
Procainamide—Flushing—Zoledronate—osteoporosis	0.000784	0.00267	CcSEcCtD
Procainamide—Cardiac disorder—Zoledronate—osteoporosis	0.000784	0.00267	CcSEcCtD
Procainamide—Malaise—Ethinyl Estradiol—osteoporosis	0.000784	0.00267	CcSEcCtD
Procainamide—Anorexia—Calcitriol—osteoporosis	0.000783	0.00267	CcSEcCtD
Procainamide—Abdominal discomfort—Estradiol—osteoporosis	0.00078	0.00266	CcSEcCtD
Procainamide—Angioedema—Risedronate—osteoporosis	0.000774	0.00264	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000772	0.00263	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000764	0.0026	CcSEcCtD
Procainamide—Chills—Zoledronate—osteoporosis	0.000758	0.00258	CcSEcCtD
Procainamide—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000755	0.00257	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000748	0.00255	CcSEcCtD
Procainamide—Ill-defined disorder—Pamidronate—osteoporosis	0.000747	0.00255	CcSEcCtD
Procainamide—Hypersensitivity—Etidronic acid—osteoporosis	0.000745	0.00254	CcSEcCtD
Procainamide—Angioedema—Pamidronate—osteoporosis	0.000736	0.00251	CcSEcCtD
Procainamide—Discomfort—Ethinyl Estradiol—osteoporosis	0.000731	0.00249	CcSEcCtD
Procainamide—Decreased appetite—Ibandronate—osteoporosis	0.000729	0.00248	CcSEcCtD
Procainamide—Malaise—Pamidronate—osteoporosis	0.000726	0.00247	CcSEcCtD
Procainamide—Depression—Estradiol—osteoporosis	0.000723	0.00246	CcSEcCtD
Procainamide—Myalgia—Risedronate—osteoporosis	0.000721	0.00246	CcSEcCtD
Procainamide—Arthralgia—Risedronate—osteoporosis	0.000721	0.00246	CcSEcCtD
Procainamide—Dysgeusia—Zoledronate—osteoporosis	0.00072	0.00245	CcSEcCtD
Procainamide—Pruritus—Etidronic acid—osteoporosis	0.000715	0.00244	CcSEcCtD
Procainamide—Gastrointestinal pain—Estropipate—osteoporosis	0.000715	0.00244	CcSEcCtD
Procainamide—Decreased appetite—Calcitriol—osteoporosis	0.000714	0.00243	CcSEcCtD
Procainamide—Feeling abnormal—Alendronate—osteoporosis	0.00071	0.00242	CcSEcCtD
Procainamide—Gastrointestinal pain—Alendronate—osteoporosis	0.000705	0.0024	CcSEcCtD
Procainamide—Convulsion—Pamidronate—osteoporosis	0.000698	0.00238	CcSEcCtD
Procainamide—Urticaria—Estropipate—osteoporosis	0.000695	0.00237	CcSEcCtD
Procainamide—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000694	0.00236	CcSEcCtD
Procainamide—Gastrointestinal pain—Raloxifene—osteoporosis	0.000693	0.00236	CcSEcCtD
Procainamide—Diarrhoea—Etidronic acid—osteoporosis	0.000692	0.00236	CcSEcCtD
Procainamide—Abdominal pain—Estropipate—osteoporosis	0.000692	0.00236	CcSEcCtD
Procainamide—Body temperature increased—Estropipate—osteoporosis	0.000692	0.00236	CcSEcCtD
Procainamide—Feeling abnormal—Ibandronate—osteoporosis	0.000691	0.00236	CcSEcCtD
Procainamide—Gastrointestinal pain—Ibandronate—osteoporosis	0.000686	0.00234	CcSEcCtD
Procainamide—Myalgia—Pamidronate—osteoporosis	0.000686	0.00234	CcSEcCtD
Procainamide—Arthralgia—Pamidronate—osteoporosis	0.000686	0.00234	CcSEcCtD
Procainamide—Urticaria—Alendronate—osteoporosis	0.000685	0.00233	CcSEcCtD
Procainamide—Ill-defined disorder—Zoledronate—osteoporosis	0.000683	0.00233	CcSEcCtD
Procainamide—Abdominal pain—Alendronate—osteoporosis	0.000681	0.00232	CcSEcCtD
Procainamide—Body temperature increased—Alendronate—osteoporosis	0.000681	0.00232	CcSEcCtD
Procainamide—Shock—Risedronate—osteoporosis	0.00068	0.00232	CcSEcCtD
Procainamide—Discomfort—Pamidronate—osteoporosis	0.000677	0.00231	CcSEcCtD
Procainamide—Angioedema—Zoledronate—osteoporosis	0.000672	0.00229	CcSEcCtD
Procainamide—Gastrointestinal pain—Calcitriol—osteoporosis	0.000672	0.00229	CcSEcCtD
Procainamide—Body temperature increased—Raloxifene—osteoporosis	0.00067	0.00228	CcSEcCtD
Procainamide—Abdominal pain—Raloxifene—osteoporosis	0.00067	0.00228	CcSEcCtD
Procainamide—Urticaria—Ibandronate—osteoporosis	0.000667	0.00227	CcSEcCtD
Procainamide—Malaise—Zoledronate—osteoporosis	0.000663	0.00226	CcSEcCtD
Procainamide—Abdominal pain—Ibandronate—osteoporosis	0.000663	0.00226	CcSEcCtD
Procainamide—Body temperature increased—Ibandronate—osteoporosis	0.000663	0.00226	CcSEcCtD
Procainamide—Confusional state—Pamidronate—osteoporosis	0.000663	0.00226	CcSEcCtD
Procainamide—Urticaria—Calcitriol—osteoporosis	0.000652	0.00222	CcSEcCtD
Procainamide—Abdominal pain—Calcitriol—osteoporosis	0.000649	0.00221	CcSEcCtD
Procainamide—Body temperature increased—Calcitriol—osteoporosis	0.000649	0.00221	CcSEcCtD
Procainamide—Angioedema—Conjugated Estrogens—osteoporosis	0.000647	0.0022	CcSEcCtD
Procainamide—Shock—Pamidronate—osteoporosis	0.000647	0.0022	CcSEcCtD
Procainamide—Hypersensitivity—Estropipate—osteoporosis	0.000645	0.0022	CcSEcCtD
Procainamide—Thrombocytopenia—Pamidronate—osteoporosis	0.000644	0.00219	CcSEcCtD
Procainamide—Vomiting—Etidronic acid—osteoporosis	0.000643	0.00219	CcSEcCtD
Procainamide—Convulsion—Zoledronate—osteoporosis	0.000637	0.00217	CcSEcCtD
Procainamide—Hypersensitivity—Alendronate—osteoporosis	0.000635	0.00216	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00063	0.00215	CcSEcCtD
Procainamide—Asthenia—Estropipate—osteoporosis	0.000628	0.00214	CcSEcCtD
Procainamide—Anorexia—Pamidronate—osteoporosis	0.000627	0.00213	CcSEcCtD
Procainamide—Myalgia—Zoledronate—osteoporosis	0.000626	0.00213	CcSEcCtD
Procainamide—Arthralgia—Zoledronate—osteoporosis	0.000626	0.00213	CcSEcCtD
Procainamide—Pruritus—Estropipate—osteoporosis	0.000619	0.00211	CcSEcCtD
Procainamide—Discomfort—Zoledronate—osteoporosis	0.000619	0.00211	CcSEcCtD
Procainamide—Asthenia—Alendronate—osteoporosis	0.000618	0.00211	CcSEcCtD
Procainamide—Hypersensitivity—Ibandronate—osteoporosis	0.000618	0.00211	CcSEcCtD
Procainamide—Hypotension—Pamidronate—osteoporosis	0.000614	0.00209	CcSEcCtD
Procainamide—Convulsion—Conjugated Estrogens—osteoporosis	0.000614	0.00209	CcSEcCtD
Procainamide—Pruritus—Alendronate—osteoporosis	0.00061	0.00208	CcSEcCtD
Procainamide—Confusional state—Zoledronate—osteoporosis	0.000605	0.00206	CcSEcCtD
Procainamide—Hypersensitivity—Calcitriol—osteoporosis	0.000605	0.00206	CcSEcCtD
Procainamide—Cardiac disorder—Estradiol—osteoporosis	0.000604	0.00206	CcSEcCtD
Procainamide—Flushing—Estradiol—osteoporosis	0.000604	0.00206	CcSEcCtD
Procainamide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000603	0.00205	CcSEcCtD
Procainamide—Myalgia—Conjugated Estrogens—osteoporosis	0.000603	0.00205	CcSEcCtD
Procainamide—Asthenia—Ibandronate—osteoporosis	0.000602	0.00205	CcSEcCtD
Procainamide—Nausea—Etidronic acid—osteoporosis	0.000601	0.00205	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000599	0.00204	CcSEcCtD
Procainamide—Diarrhoea—Estropipate—osteoporosis	0.000599	0.00204	CcSEcCtD
Procainamide—Pruritus—Ibandronate—osteoporosis	0.000594	0.00202	CcSEcCtD
Procainamide—Shock—Zoledronate—osteoporosis	0.000591	0.00201	CcSEcCtD
Procainamide—Diarrhoea—Alendronate—osteoporosis	0.00059	0.00201	CcSEcCtD
Procainamide—Asthenia—Calcitriol—osteoporosis	0.000589	0.00201	CcSEcCtD
Procainamide—Thrombocytopenia—Zoledronate—osteoporosis	0.000588	0.002	CcSEcCtD
Procainamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000584	0.00199	CcSEcCtD
Procainamide—Chills—Estradiol—osteoporosis	0.000584	0.00199	CcSEcCtD
Procainamide—Pruritus—Calcitriol—osteoporosis	0.000581	0.00198	CcSEcCtD
Procainamide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00058	0.00198	CcSEcCtD
Procainamide—Diarrhoea—Raloxifene—osteoporosis	0.00058	0.00198	CcSEcCtD
Procainamide—Dizziness—Estropipate—osteoporosis	0.000579	0.00197	CcSEcCtD
Procainamide—Diarrhoea—Ibandronate—osteoporosis	0.000574	0.00196	CcSEcCtD
Procainamide—Anorexia—Zoledronate—osteoporosis	0.000572	0.00195	CcSEcCtD
Procainamide—Decreased appetite—Pamidronate—osteoporosis	0.000571	0.00195	CcSEcCtD
Procainamide—Dizziness—Alendronate—osteoporosis	0.00057	0.00194	CcSEcCtD
Procainamide—Shock—Conjugated Estrogens—osteoporosis	0.000569	0.00194	CcSEcCtD
Procainamide—Gastrointestinal pain—Risedronate—osteoporosis	0.000565	0.00193	CcSEcCtD
Procainamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000563	0.00192	CcSEcCtD
Procainamide—Diarrhoea—Calcitriol—osteoporosis	0.000562	0.00191	CcSEcCtD
Procainamide—Hypotension—Zoledronate—osteoporosis	0.000561	0.00191	CcSEcCtD
Procainamide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000561	0.00191	CcSEcCtD
Procainamide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000561	0.00191	CcSEcCtD
Procainamide—Dizziness—Raloxifene—osteoporosis	0.00056	0.00191	CcSEcCtD
Procainamide—Vomiting—Estropipate—osteoporosis	0.000556	0.00189	CcSEcCtD
Procainamide—Dysgeusia—Estradiol—osteoporosis	0.000555	0.00189	CcSEcCtD
Procainamide—Dizziness—Ibandronate—osteoporosis	0.000555	0.00189	CcSEcCtD
Procainamide—Anorexia—Conjugated Estrogens—osteoporosis	0.000551	0.00188	CcSEcCtD
Procainamide—Urticaria—Risedronate—osteoporosis	0.000549	0.00187	CcSEcCtD
Procainamide—Vomiting—Alendronate—osteoporosis	0.000548	0.00187	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000547	0.00186	CcSEcCtD
Procainamide—Body temperature increased—Risedronate—osteoporosis	0.000547	0.00186	CcSEcCtD
Procainamide—Abdominal pain—Risedronate—osteoporosis	0.000547	0.00186	CcSEcCtD
Procainamide—Feeling abnormal—Pamidronate—osteoporosis	0.000542	0.00185	CcSEcCtD
Procainamide—Hypotension—Conjugated Estrogens—osteoporosis	0.00054	0.00184	CcSEcCtD
Procainamide—Vomiting—Raloxifene—osteoporosis	0.000539	0.00184	CcSEcCtD
Procainamide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000537	0.00183	CcSEcCtD
Procainamide—Vomiting—Ibandronate—osteoporosis	0.000533	0.00182	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000527	0.00179	CcSEcCtD
Procainamide—Ill-defined disorder—Estradiol—osteoporosis	0.000526	0.00179	CcSEcCtD
Procainamide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000522	0.00178	CcSEcCtD
Procainamide—Vomiting—Calcitriol—osteoporosis	0.000522	0.00178	CcSEcCtD
Procainamide—Decreased appetite—Zoledronate—osteoporosis	0.000522	0.00178	CcSEcCtD
Procainamide—Nausea—Estropipate—osteoporosis	0.00052	0.00177	CcSEcCtD
Procainamide—Body temperature increased—Pamidronate—osteoporosis	0.00052	0.00177	CcSEcCtD
Procainamide—Abdominal pain—Pamidronate—osteoporosis	0.00052	0.00177	CcSEcCtD
Procainamide—Angioedema—Estradiol—osteoporosis	0.000518	0.00176	CcSEcCtD
Procainamide—Nausea—Alendronate—osteoporosis	0.000512	0.00174	CcSEcCtD
Procainamide—Malaise—Estradiol—osteoporosis	0.000511	0.00174	CcSEcCtD
Procainamide—Hypersensitivity—Risedronate—osteoporosis	0.000509	0.00174	CcSEcCtD
Procainamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000509	0.00173	CcSEcCtD
Procainamide—Nausea—Raloxifene—osteoporosis	0.000503	0.00171	CcSEcCtD
Procainamide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000503	0.00171	CcSEcCtD
Procainamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000502	0.00171	CcSEcCtD
Procainamide—Nausea—Ibandronate—osteoporosis	0.000498	0.0017	CcSEcCtD
Procainamide—Asthenia—Risedronate—osteoporosis	0.000496	0.00169	CcSEcCtD
Procainamide—Feeling abnormal—Zoledronate—osteoporosis	0.000495	0.00169	CcSEcCtD
Procainamide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000491	0.00167	CcSEcCtD
Procainamide—Pruritus—Risedronate—osteoporosis	0.000489	0.00167	CcSEcCtD
Procainamide—Nausea—Calcitriol—osteoporosis	0.000488	0.00166	CcSEcCtD
Procainamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000485	0.00165	CcSEcCtD
Procainamide—Hypersensitivity—Pamidronate—osteoporosis	0.000484	0.00165	CcSEcCtD
Procainamide—Myalgia—Estradiol—osteoporosis	0.000483	0.00164	CcSEcCtD
Procainamide—Arthralgia—Estradiol—osteoporosis	0.000483	0.00164	CcSEcCtD
Procainamide—Urticaria—Zoledronate—osteoporosis	0.000477	0.00162	CcSEcCtD
Procainamide—Discomfort—Estradiol—osteoporosis	0.000477	0.00162	CcSEcCtD
Procainamide—Abdominal pain—Zoledronate—osteoporosis	0.000475	0.00162	CcSEcCtD
Procainamide—Body temperature increased—Zoledronate—osteoporosis	0.000475	0.00162	CcSEcCtD
Procainamide—Diarrhoea—Risedronate—osteoporosis	0.000473	0.00161	CcSEcCtD
Procainamide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000473	0.00161	CcSEcCtD
Procainamide—Asthenia—Pamidronate—osteoporosis	0.000472	0.00161	CcSEcCtD
Procainamide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000469	0.0016	CcSEcCtD
Procainamide—Confusional state—Estradiol—osteoporosis	0.000467	0.00159	CcSEcCtD
Procainamide—Pruritus—Pamidronate—osteoporosis	0.000465	0.00158	CcSEcCtD
Procainamide—Urticaria—Conjugated Estrogens—osteoporosis	0.000459	0.00156	CcSEcCtD
Procainamide—Dizziness—Risedronate—osteoporosis	0.000457	0.00156	CcSEcCtD
Procainamide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000457	0.00156	CcSEcCtD
Procainamide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000457	0.00156	CcSEcCtD
Procainamide—Shock—Estradiol—osteoporosis	0.000455	0.00155	CcSEcCtD
Procainamide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000451	0.00154	CcSEcCtD
Procainamide—Diarrhoea—Pamidronate—osteoporosis	0.00045	0.00153	CcSEcCtD
Procainamide—Hypersensitivity—Zoledronate—osteoporosis	0.000442	0.00151	CcSEcCtD
Procainamide—Vomiting—Risedronate—osteoporosis	0.00044	0.0015	CcSEcCtD
Procainamide—Dizziness—Pamidronate—osteoporosis	0.000435	0.00148	CcSEcCtD
Procainamide—Asthenia—Zoledronate—osteoporosis	0.000431	0.00147	CcSEcCtD
Procainamide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000426	0.00145	CcSEcCtD
Procainamide—Pruritus—Zoledronate—osteoporosis	0.000425	0.00145	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000422	0.00144	CcSEcCtD
Procainamide—Nausea—Ethinyl Estradiol—osteoporosis	0.000421	0.00143	CcSEcCtD
Procainamide—Vomiting—Pamidronate—osteoporosis	0.000418	0.00142	CcSEcCtD
Procainamide—Asthenia—Conjugated Estrogens—osteoporosis	0.000415	0.00141	CcSEcCtD
Procainamide—Diarrhoea—Zoledronate—osteoporosis	0.000411	0.0014	CcSEcCtD
Procainamide—Nausea—Risedronate—osteoporosis	0.000411	0.0014	CcSEcCtD
Procainamide—Pruritus—Conjugated Estrogens—osteoporosis	0.000409	0.00139	CcSEcCtD
Procainamide—Decreased appetite—Estradiol—osteoporosis	0.000402	0.00137	CcSEcCtD
Procainamide—Dizziness—Zoledronate—osteoporosis	0.000397	0.00135	CcSEcCtD
Procainamide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000396	0.00135	CcSEcCtD
Procainamide—Nausea—Pamidronate—osteoporosis	0.00039	0.00133	CcSEcCtD
Procainamide—Dizziness—Conjugated Estrogens—osteoporosis	0.000382	0.0013	CcSEcCtD
Procainamide—Vomiting—Zoledronate—osteoporosis	0.000382	0.0013	CcSEcCtD
Procainamide—Feeling abnormal—Estradiol—osteoporosis	0.000381	0.0013	CcSEcCtD
Procainamide—Gastrointestinal pain—Estradiol—osteoporosis	0.000378	0.00129	CcSEcCtD
Procainamide—Vomiting—Conjugated Estrogens—osteoporosis	0.000368	0.00125	CcSEcCtD
Procainamide—Urticaria—Estradiol—osteoporosis	0.000368	0.00125	CcSEcCtD
Procainamide—Body temperature increased—Estradiol—osteoporosis	0.000366	0.00125	CcSEcCtD
Procainamide—Abdominal pain—Estradiol—osteoporosis	0.000366	0.00125	CcSEcCtD
Procainamide—Nausea—Zoledronate—osteoporosis	0.000357	0.00121	CcSEcCtD
Procainamide—Nausea—Conjugated Estrogens—osteoporosis	0.000343	0.00117	CcSEcCtD
Procainamide—Hypersensitivity—Estradiol—osteoporosis	0.000341	0.00116	CcSEcCtD
Procainamide—Asthenia—Estradiol—osteoporosis	0.000332	0.00113	CcSEcCtD
Procainamide—Pruritus—Estradiol—osteoporosis	0.000327	0.00112	CcSEcCtD
Procainamide—Diarrhoea—Estradiol—osteoporosis	0.000317	0.00108	CcSEcCtD
Procainamide—Dizziness—Estradiol—osteoporosis	0.000306	0.00104	CcSEcCtD
Procainamide—Vomiting—Estradiol—osteoporosis	0.000294	0.001	CcSEcCtD
Procainamide—Nausea—Estradiol—osteoporosis	0.000275	0.000936	CcSEcCtD
Procainamide—SLC22A3—Metabolism—IDH2—osteoporosis	8.18e-05	0.000878	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ATIC—osteoporosis	8.15e-05	0.000875	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PNP—osteoporosis	8.15e-05	0.000875	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—ADCY5—osteoporosis	8.04e-05	0.000863	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—MGLL—osteoporosis	8.02e-05	0.000861	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6R—osteoporosis	8.01e-05	0.000859	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PGLS—osteoporosis	7.96e-05	0.000854	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPD2—osteoporosis	7.96e-05	0.000854	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TGFB1—osteoporosis	7.92e-05	0.00085	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—FDPS—osteoporosis	7.83e-05	0.00084	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PKM—osteoporosis	7.83e-05	0.00084	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PTHLH—osteoporosis	7.77e-05	0.000834	CbGpPWpGaD
Procainamide—ACHE—Metabolism—OXCT1—osteoporosis	7.77e-05	0.000834	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CA2—osteoporosis	7.77e-05	0.000834	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP27A1—osteoporosis	7.69e-05	0.000825	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—ADCY5—osteoporosis	7.66e-05	0.000822	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—IL6—osteoporosis	7.65e-05	0.000821	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	7.63e-05	0.000819	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MGLL—osteoporosis	7.57e-05	0.000813	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	7.52e-05	0.000807	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ACP5—osteoporosis	7.48e-05	0.000803	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPD2—osteoporosis	7.42e-05	0.000796	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PGLS—osteoporosis	7.42e-05	0.000796	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—osteoporosis	7.39e-05	0.000794	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—LEP—osteoporosis	7.37e-05	0.000791	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MGLL—osteoporosis	7.28e-05	0.000781	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PNP—osteoporosis	7.28e-05	0.000781	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ATIC—osteoporosis	7.28e-05	0.000781	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TGFB1—osteoporosis	7.24e-05	0.000777	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.14e-05	0.000766	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.05e-05	0.000756	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.02e-05	0.000754	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TPI1—osteoporosis	6.95e-05	0.000746	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—ACE—osteoporosis	6.95e-05	0.000746	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CA2—osteoporosis	6.93e-05	0.000744	CbGpPWpGaD
Procainamide—BCHE—Metabolism—OXCT1—osteoporosis	6.93e-05	0.000744	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	6.91e-05	0.000742	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CALCA—osteoporosis	6.84e-05	0.000735	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PNP—osteoporosis	6.79e-05	0.000728	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ATIC—osteoporosis	6.79e-05	0.000728	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—osteoporosis	6.76e-05	0.000726	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MGLL—osteoporosis	6.75e-05	0.000725	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—IL6—osteoporosis	6.7e-05	0.000719	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—ESR1—osteoporosis	6.64e-05	0.000712	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—P4HB—osteoporosis	6.54e-05	0.000702	CbGpPWpGaD
Procainamide—ACHE—Metabolism—IDH2—osteoporosis	6.44e-05	0.000691	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GAPDH—osteoporosis	6.42e-05	0.000689	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.37e-05	0.000684	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—RAP1A—osteoporosis	6.25e-05	0.000671	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—ACE—osteoporosis	6.2e-05	0.000665	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—OXCT1—osteoporosis	6.19e-05	0.000664	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CA2—osteoporosis	6.19e-05	0.000664	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—IL6—osteoporosis	6.19e-05	0.000664	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6R—osteoporosis	6.17e-05	0.000663	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL1B—osteoporosis	6.09e-05	0.000654	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP27A1—osteoporosis	6.05e-05	0.00065	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MGLL—osteoporosis	6.03e-05	0.000648	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOST—osteoporosis	5.99e-05	0.000643	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—IL6—osteoporosis	5.97e-05	0.000641	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.94e-05	0.000638	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.93e-05	0.000636	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—IL6—osteoporosis	5.92e-05	0.000635	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—POMC—osteoporosis	5.91e-05	0.000635	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ACP5—osteoporosis	5.89e-05	0.000632	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TGFB1—osteoporosis	5.86e-05	0.000629	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.81e-05	0.000624	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—OXCT1—osteoporosis	5.77e-05	0.000619	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CA2—osteoporosis	5.77e-05	0.000619	CbGpPWpGaD
Procainamide—BCHE—Metabolism—IDH2—osteoporosis	5.74e-05	0.000616	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—IL6—osteoporosis	5.68e-05	0.00061	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—IL6—osteoporosis	5.68e-05	0.00061	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MGLL—osteoporosis	5.62e-05	0.000604	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TGFB1—osteoporosis	5.6e-05	0.000601	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.53e-05	0.000594	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—osteoporosis	5.48e-05	0.000588	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—osteoporosis	5.48e-05	0.000588	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TPI1—osteoporosis	5.47e-05	0.000588	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—osteoporosis	5.47e-05	0.000587	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—osteoporosis	5.46e-05	0.000586	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTH1R—osteoporosis	5.41e-05	0.000581	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALCR—osteoporosis	5.41e-05	0.000581	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP27A1—osteoporosis	5.4e-05	0.00058	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—osteoporosis	5.38e-05	0.000578	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—osteoporosis	5.38e-05	0.000578	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PTH—osteoporosis	5.3e-05	0.000569	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ACP5—osteoporosis	5.25e-05	0.000564	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—osteoporosis	5.23e-05	0.000562	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—osteoporosis	5.19e-05	0.000557	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TGFB1—osteoporosis	5.19e-05	0.000557	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.19e-05	0.000557	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	5.17e-05	0.000555	CbGpPWpGaD
Procainamide—ACHE—Metabolism—P4HB—osteoporosis	5.15e-05	0.000552	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—IDH2—osteoporosis	5.13e-05	0.000551	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ENO1—osteoporosis	5.05e-05	0.000542	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GAPDH—osteoporosis	5.05e-05	0.000542	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—osteoporosis	5.03e-05	0.00054	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—osteoporosis	5.03e-05	0.00054	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PSMA5—osteoporosis	4.98e-05	0.000534	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PSMA2—osteoporosis	4.98e-05	0.000534	CbGpPWpGaD
Procainamide—ACHE—Metabolism—RAP1A—osteoporosis	4.92e-05	0.000528	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TPI1—osteoporosis	4.88e-05	0.000524	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—osteoporosis	4.85e-05	0.00052	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—osteoporosis	4.85e-05	0.00052	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP27A1—osteoporosis	4.82e-05	0.000518	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTH—osteoporosis	4.81e-05	0.000517	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—IDH2—osteoporosis	4.78e-05	0.000513	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.7e-05	0.000505	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CNR2—osteoporosis	4.69e-05	0.000504	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ACP5—osteoporosis	4.69e-05	0.000504	CbGpPWpGaD
Procainamide—BCHE—Metabolism—P4HB—osteoporosis	4.59e-05	0.000493	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—osteoporosis	4.58e-05	0.000492	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GAPDH—osteoporosis	4.51e-05	0.000484	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP27A1—osteoporosis	4.5e-05	0.000482	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	4.42e-05	0.000474	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.42e-05	0.000474	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—osteoporosis	4.41e-05	0.000474	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—WNT1—osteoporosis	4.41e-05	0.000473	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	4.39e-05	0.000472	CbGpPWpGaD
Procainamide—BCHE—Metabolism—RAP1A—osteoporosis	4.39e-05	0.000471	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ACP5—osteoporosis	4.37e-05	0.000469	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TPI1—osteoporosis	4.36e-05	0.000468	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FDPS—osteoporosis	4.32e-05	0.000464	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PKM—osteoporosis	4.32e-05	0.000464	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—LEP—osteoporosis	4.32e-05	0.000463	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MGLL—osteoporosis	4.3e-05	0.000462	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.29e-05	0.000461	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—osteoporosis	4.22e-05	0.000453	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LRP5—osteoporosis	4.2e-05	0.000451	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.12e-05	0.000442	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—P4HB—osteoporosis	4.1e-05	0.00044	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPD2—osteoporosis	4.1e-05	0.00044	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PGLS—osteoporosis	4.1e-05	0.00044	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TPI1—osteoporosis	4.07e-05	0.000436	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—osteoporosis	4.06e-05	0.000435	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—osteoporosis	4.06e-05	0.000435	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP19A1—osteoporosis	4.04e-05	0.000434	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GAPDH—osteoporosis	4.03e-05	0.000432	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LRP6—osteoporosis	4.02e-05	0.000431	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	3.99e-05	0.000428	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ENO1—osteoporosis	3.98e-05	0.000427	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—RAP1A—osteoporosis	3.92e-05	0.000421	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PSMA2—osteoporosis	3.92e-05	0.000421	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PSMA5—osteoporosis	3.92e-05	0.000421	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—osteoporosis	3.91e-05	0.00042	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—osteoporosis	3.91e-05	0.00042	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	3.87e-05	0.000415	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—osteoporosis	3.85e-05	0.000414	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—LEP—osteoporosis	3.85e-05	0.000413	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.83e-05	0.000411	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—P4HB—osteoporosis	3.82e-05	0.00041	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GAPDH—osteoporosis	3.75e-05	0.000403	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ATIC—osteoporosis	3.75e-05	0.000402	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PNP—osteoporosis	3.75e-05	0.000402	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—osteoporosis	3.71e-05	0.000398	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—RAP1A—osteoporosis	3.65e-05	0.000392	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—osteoporosis	3.65e-05	0.000392	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—osteoporosis	3.58e-05	0.000384	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	3.57e-05	0.000383	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF1—osteoporosis	3.57e-05	0.000383	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ENO1—osteoporosis	3.55e-05	0.000381	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CALCA—osteoporosis	3.51e-05	0.000377	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PSMA5—osteoporosis	3.5e-05	0.000375	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PSMA2—osteoporosis	3.5e-05	0.000375	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—osteoporosis	3.45e-05	0.000371	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—osteoporosis	3.41e-05	0.000366	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TLN1—osteoporosis	3.39e-05	0.000364	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—osteoporosis	3.31e-05	0.000355	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ADCY5—osteoporosis	3.3e-05	0.000354	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GPX1—osteoporosis	3.29e-05	0.000353	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CA2—osteoporosis	3.19e-05	0.000342	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—OXCT1—osteoporosis	3.19e-05	0.000342	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—osteoporosis	3.18e-05	0.000341	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP19A1—osteoporosis	3.18e-05	0.000341	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ENO1—osteoporosis	3.17e-05	0.00034	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PSMA2—osteoporosis	3.12e-05	0.000335	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PSMA5—osteoporosis	3.12e-05	0.000335	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MGLL—osteoporosis	3.11e-05	0.000333	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—osteoporosis	3.04e-05	0.000326	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ENO1—osteoporosis	2.95e-05	0.000317	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—P4HB—osteoporosis	2.92e-05	0.000314	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PSMA5—osteoporosis	2.91e-05	0.000312	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PSMA2—osteoporosis	2.91e-05	0.000312	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTH—osteoporosis	2.84e-05	0.000305	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP19A1—osteoporosis	2.84e-05	0.000304	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RAP1A—osteoporosis	2.79e-05	0.0003	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CNR2—osteoporosis	2.77e-05	0.000297	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	2.75e-05	0.000295	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—osteoporosis	2.75e-05	0.000295	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFATC1—osteoporosis	2.73e-05	0.000293	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DKK1—osteoporosis	2.71e-05	0.00029	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—IDH2—osteoporosis	2.64e-05	0.000283	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WNT1—osteoporosis	2.61e-05	0.00028	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADCY5—osteoporosis	2.6e-05	0.000279	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GPX1—osteoporosis	2.59e-05	0.000278	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGA—osteoporosis	2.53e-05	0.000272	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP19A1—osteoporosis	2.53e-05	0.000272	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	2.5e-05	0.000268	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.48e-05	0.000266	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—osteoporosis	2.43e-05	0.000261	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ACP5—osteoporosis	2.42e-05	0.000259	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—osteoporosis	2.39e-05	0.000256	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP19A1—osteoporosis	2.36e-05	0.000253	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTHLH—osteoporosis	2.36e-05	0.000253	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BMP2—osteoporosis	2.36e-05	0.000253	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADCY5—osteoporosis	2.32e-05	0.000249	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX1—osteoporosis	2.31e-05	0.000248	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGB—osteoporosis	2.31e-05	0.000248	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TPI1—osteoporosis	2.25e-05	0.000241	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSMA5—osteoporosis	2.23e-05	0.000239	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSMA2—osteoporosis	2.23e-05	0.000239	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—osteoporosis	2.13e-05	0.000229	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—P4HB—osteoporosis	2.11e-05	0.000227	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALCA—osteoporosis	2.07e-05	0.000223	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GAPDH—osteoporosis	2.07e-05	0.000222	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADCY5—osteoporosis	2.07e-05	0.000222	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX1—osteoporosis	2.06e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—osteoporosis	2.02e-05	0.000217	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—RAP1A—osteoporosis	2.02e-05	0.000217	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADCY5—osteoporosis	1.93e-05	0.000207	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX1—osteoporosis	1.92e-05	0.000206	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—osteoporosis	1.91e-05	0.000205	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—osteoporosis	1.9e-05	0.000204	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KL—osteoporosis	1.88e-05	0.000202	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.84e-05	0.000197	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.79e-05	0.000192	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—osteoporosis	1.77e-05	0.00019	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—osteoporosis	1.7e-05	0.000183	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ENO1—osteoporosis	1.63e-05	0.000175	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSMA2—osteoporosis	1.61e-05	0.000173	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSMA5—osteoporosis	1.61e-05	0.000173	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—osteoporosis	1.52e-05	0.000163	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.48e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.43e-05	0.000153	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—osteoporosis	1.42e-05	0.000152	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.3e-05	0.00014	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.29e-05	0.000139	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—osteoporosis	1.26e-05	0.000136	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.21e-05	0.000129	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.13e-05	0.000121	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—osteoporosis	1.09e-05	0.000117	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADCY5—osteoporosis	1.07e-05	0.000114	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX1—osteoporosis	1.06e-05	0.000114	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.06e-05	0.000114	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.04e-05	0.000112	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—osteoporosis	9.8e-06	0.000105	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—osteoporosis	7.98e-06	8.57e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—osteoporosis	7.84e-06	8.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—osteoporosis	6.27e-06	6.74e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—osteoporosis	6.26e-06	6.72e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—osteoporosis	4.72e-06	5.06e-05	CbGpPWpGaD
